As you know, dry eye is a growing problem in the US and worldwide. Reports indicate more than 117+ million Americans use eye drops at least once a year.
Scope Eyecare, a family-owned independent company based in Dublin, Ireland, launched OPTASE® in the US in 2019. With a Heat-Cleanse-Hydrate regimen based on DEWS II, OPTASE® strives to bring the most advanced OTC solutions to the US and is a worthy partner to all eye doctors. In addition to the OPTASE® line of highly advanced preservative-free lubricants, Scope is thrilled to launch its latest dry eye drop: OPTASE® HYLO FORTE.
With over $1 billion in OTC dry eye products sold annually at national retailers in the US, OPTASE® has entered the market with an aggressive wholesale price structure, allowing OD practices to increase patient compliance, increase practice revenue, and offer the most advanced molecules and delivery systems to patients by stocking products in practice.
The Member Special Pricing offer with ODs on Finance is 15% off. OPTASE® offers you the best pricing on our full line of eyecare products.
OPTASE® is excited to present an exclusive offer at Vision Expo West in Las Vegas from Septemer 17th to September 20th: An Extra 5% OFF & BUY 25 OPTASE® HYLO FORTE, GET 5 Free! Visit OPTASE at Stand F10081 at VEW.
